Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

OPERATING SEGMENTS

v3.26.1
OPERATING SEGMENTS
 12 Months Ended
Dec. 31, 2025
Disclosure of operating segments [abstract]  
OPERATING SEGMENTS [Text Block]
NOTE 21 -
OPERATING SEGMENTS
 
  A.
General information:
 
Since inception date, the operation of the Group has been conducted through one operating segment, (i.e., sales of medical cannabis products and other products) to customers through certain geographical areas (i.e. Israel and Germany).
 
   
Israel
    
Germany
    
Adjustments
    
Total
  
 Year ended December 31, 2025
                        
                         
 Revenue
  
$
18,383
    
$
36,348
    
$
-
    
$
54,731
  
                                 
 Segment loss
  
$
(6,839
)
  
$
(1,674
)
  
$
-
    
$
(8,513
)
                                 
 Unallocated corporate expenses
                  
$
(3,074
)
  
$
(3,074
)
                                 
 Total operating loss
                          
$
(11,587
)
                                 
 Depreciation, amortization and impairment
  
$
7,175
    
$
1,168
    
$
-
    
$
8,343
  
 
 Year ended December 31, 2024
                        
                         
 Revenue
  
$
38,523
    
$
15,508
    
$
-
    
$
54,031
  
                                 
 Segment loss (income)
  
$
(9,314
)
  
$
942
    
$
-
    
$
(8,372
)
                                 
 Unallocated corporate expenses
                  
$
(1,862
)
  
$
(1,862
)
                                 
 Total operating loss
                          
$
(10,234
)
                                 
 Depreciation, amortization and impairment
  
$
2,509
    
$
170
    
$
-
    
$
2,679
  
 
 Year ended December 31, 2023
                        
                         
 Revenue
  
$
43,316
    
$
5,488
    
$
-
    
$
48,804
  
                                 
 Segment loss
  
$
(6,627
)
  
$
(1,615
)
  
$
-
    
$
(8,242
)
                                 
 Unallocated corporate expenses
                  
$
(4,550
)
  
$
(4,550
)
                                 
 Total operating loss
                          
$
(12,792
)
                                 
 Depreciation, amortization and impairment
  
$
2,823
    
$
173
    
$
-
    
$
2,996
  
 
  B.
Major customers
 
During the years ended December 31, 2025 and 2024, the Company had major customers which accounted for approximately 13% and 32% of the Group's total revenue, respectively. During the year ended December 31, 2023, the Company had no customers that exceeded 10% of the Group's total revenue.